Quality of life in patients with allergic rhinitis

Annals of Allergy, Asthma and Immunology

Volumn 85, Issue 5, 2000, Pages 338-344

  Thompson, A K ^a   Juniper, E ^a   Meltzer, E O ^a  

^a Aventis Pharmaceuticals   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ALLERGIC RHINITIS; CHILD; COST BENEFIT ANALYSIS; HUMAN; PRIORITY JOURNAL; PSYCHOLOGICAL ASPECT; QUALITY OF LIFE; REIMBURSEMENT; REVIEW; RISK BENEFIT ANALYSIS; SOCIAL ASPECT; SYMPTOMATOLOGY;

EID: 0033661355     PISSN: 10811206     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1081-1206(10)62543-4     Document Type: Review

References (39)

1. Prevalence of allergic rhinitis in the United States
2. Rhinitis management: The patient's perspective
3. Impact of upper respiratory allergic diseases on quality of life
4. A pharmacologic continuum in the treatment of rhinorrhea: The clinician as economist
5. The relationships between nasal hyperreactivity, quality of life, and nasal symptoms in patients with perennial allergic rhinitis
6. Quality of life and rhinitic symptoms: Results of a nationwide survey with the SF-36 and RQLQ questionnaires
7. Quality of life in allergic rhinitis
8. Improvement of quality of life by treatment with cetirizine in patients with perennial allergic rhinitis as determined by a French version of the SF-36 questionnaire
9. Superior improvement in disease-specific quality of life for SAR patients receiving intranasal fluticasone vs loratadine tablets
10. Comparison of powder and aerosolized budesonide in perennial rhinitis: Validation of rhinitis quality of life questionnaire
11. The MOS 36-item short-form health survey (SF-36)
12. Impact of quality of life during an allergen challenge research trial
13. Measuring health-related quality of life
14. Development and testing of a new measure of health status for clinical trials in rhinoconjunctivitis
15. The validity and reproducibility of a work productivity and activity impairment instrument
16. Work, classroom, and activity impairment instruments
17. Assessment of quality of life in adolescents with allergic rhinoconjunctivitis: Development and testing of a questionnaire for clinical trials
18. Measuring quality of life in children with rhinoconjunctivitis
19. Development and validation of the mini rhinoconjunctivitis quality of life questionnaire
20. Electronic implementation of quality of life measures in asthma
21. Development of a nasal comfort index for nasal sprays in adults with seasonal allergic rhinitis
22. Effect of fexofenadine on quality of life and work, classroom, and daily activity impairment in patients with seasonal allergic rhinitis
23. Once-daily fexofenadine HCl improves quality of life and reduces work and activity impairment in patients with seasonal allergic rhinitis
24. Effects of allergy season on mood and cognitive function
25. Learning impairment and allergic rhinitis
26. Seasonal allergic rhinitis and antihistamine effects on children's learning
27. Why outcomes?
28. Comparison of ipratropium bromide 0.03% with beclomethasone dipropionate in the treatment of perennial rhinitis in children
29. The cost of care and quality of life in patients with allergic rhinitis on allergen immunotherapy
30. Comparison of the efficacy, safety, and quality of life provided by fexofenadine hydrochloride 120 mg, loratadine 10 mg, and placebo administered once daily for the treatment of seasonal allergic rhinitis
31. A comparison of the efficacy of fluticasone propionate aqueous nasal spray and loratadine alone and in combination, for the treatment of seasonal allergic rhinitis
32. Quality of life questionnaires: Does statistically significant equal clinically important? Editorial
33. Interpretation of quality of life changes
34. Measurement of health status
35. Determining a minimal important change in a disease-specific quality of life questionnaire
36. Interpreting of Quality of Life Data
37. The number needed to treat: A clinically useful nomogram in its proper context
38. Validation of the standardized version of the Rhinoconjunctivitis Quality of Life Questionnaire